FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2740620121> ?p ?o ?g. }

• W2740620121 abstract "The analysis of extracellular vesicles (EVs) in biofluids is an expanding area of biomarker discovery. To be effective, a diagnostic test must differentiate EVs originating from cancer cells versus non-cancerous origins, and also define biomarkers enriched in cancer EVs. Our team has developed a micro-flow cytometry platform using the Apogee A50 to analyze prostate cancer (PCa) EVs in different biofluids. While flow cytometry is powerful tool for quantitative and qualitative evaluation of cellular biomarkers, direct translation of most applications to EVs is challenging. For example, EVs in biofluids typically range in size from 50-1000nm, and are present as low refractive index, polydisperse populations. We have optimized 30 assay parameters for the identification of prostate specific EVs so that disease specific biomarkers may be evaluated. To illustrate the sensitivity of the system, conditioned media from palmitoylated-GFP-LNCaP cells was used as a positive signal sample. When spiked into increasing concentrations of unstained plasma EVs, the GFP spike was detected linearly, even when present as low as 0.03% of the total EV population. Furthermore, the rate of positive signal/uL sample was quantitative after 15-30 seconds of sample analysis. The platform also permits high throughput analysis using a 96 well plate autosampler. To show sample reproducibility, we analyzed both low and high positive-signal samples over an 8hr sampling window. Low positive samples (120events/uL; 0.1% of total EVs) had a 4% CV over 96 samples whereas the high positive signal samples (2300events/uL, 1.0% of total EVs) had a 2.2% CV. Similar CVs have been obtained with CD9 and CD63. Analysis of sample aliquots over multiple days shows less than 6% CV. Conventional flow cytometers acquire tens of thousands of events while the Apogee system is able to collect millions of events with several parameters/event, in a high throughput manner. This generates a significant amount of data for which we have designed a unique machine learning approach to detect specific EV populations within the whole sample. In this manner, we utilize all data from the sample and not simply a subjectively defined area of interest. Using fresh samples from the clinic we have standardized a 2hr arm-freezer protocol for the collection and preservation of serum and plasma. Comparison studies in LNCaps and PC3 cells of 5 antibodies against PSMA, indicated the J591 anti-PSMA monoclonal antibody as a selective marker for prostate cancer EVs. Positive signal for this antibody was linearly titrated in both a LNCaP EV system and plasma EVs from metastatic prostate cancer patients. Specificity was shown by saturating a plasma system with unconjugated J591 and then reacting with PE-conjugated J591. Using the A50 micro-flow cytometry platform, the J591 antibody to identify prostate specific EVs, and a unique machine learning algorithm, we identified a multiple biomarker, diagnostic signature for PCa. Citation Format: Desmond Pink, Robert Paproski, Deborah Sosnowski, Lian Willetts, Eric Hyndman, John D. Lewis. Technical validation of a micro-flow cytometry platform for prostate cancer biomarker discovery [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 3799. doi:10.1158/1538-7445.AM2017-3799" @default.
• W2740620121 created "2017-08-08" @default.
• W2740620121 creator A5003387085 @default.
• W2740620121 creator A5007482612 @default.
• W2740620121 creator A5049759341 @default.
• W2740620121 creator A5069596587 @default.
• W2740620121 creator A5075577263 @default.
• W2740620121 creator A5089836373 @default.
• W2740620121 date "2017-07-01" @default.
• W2740620121 modified "2023-09-25" @default.
• W2740620121 title "Abstract 3799: Technical validation of a micro-flow cytometry platform for prostate cancer biomarker discovery" @default.
• W2740620121 doi "https://doi.org/10.1158/1538-7445.am2017-3799" @default.
• W2740620121 hasPublicationYear "2017" @default.
• W2740620121 type Work @default.
• W2740620121 sameAs 2740620121 @default.
• W2740620121 citedByCount "0" @default.
• W2740620121 crossrefType "proceedings-article" @default.
• W2740620121 hasAuthorship W2740620121A5003387085 @default.
• W2740620121 hasAuthorship W2740620121A5007482612 @default.
• W2740620121 hasAuthorship W2740620121A5049759341 @default.
• W2740620121 hasAuthorship W2740620121A5069596587 @default.
• W2740620121 hasAuthorship W2740620121A5075577263 @default.
• W2740620121 hasAuthorship W2740620121A5089836373 @default.
• W2740620121 hasConcept C104317684 @default.
• W2740620121 hasConcept C121608353 @default.
• W2740620121 hasConcept C124535831 @default.
• W2740620121 hasConcept C126322002 @default.
• W2740620121 hasConcept C185592680 @default.
• W2740620121 hasConcept C203014093 @default.
• W2740620121 hasConcept C2780192828 @default.
• W2740620121 hasConcept C2780339063 @default.
• W2740620121 hasConcept C2781197716 @default.
• W2740620121 hasConcept C2908647359 @default.
• W2740620121 hasConcept C2992929900 @default.
• W2740620121 hasConcept C46111723 @default.
• W2740620121 hasConcept C553184892 @default.
• W2740620121 hasConcept C55493867 @default.
• W2740620121 hasConcept C71924100 @default.
• W2740620121 hasConcept C86803240 @default.
• W2740620121 hasConcept C95444343 @default.
• W2740620121 hasConcept C99454951 @default.
• W2740620121 hasConceptScore W2740620121C104317684 @default.
• W2740620121 hasConceptScore W2740620121C121608353 @default.
• W2740620121 hasConceptScore W2740620121C124535831 @default.
• W2740620121 hasConceptScore W2740620121C126322002 @default.
• W2740620121 hasConceptScore W2740620121C185592680 @default.
• W2740620121 hasConceptScore W2740620121C203014093 @default.
• W2740620121 hasConceptScore W2740620121C2780192828 @default.
• W2740620121 hasConceptScore W2740620121C2780339063 @default.
• W2740620121 hasConceptScore W2740620121C2781197716 @default.
• W2740620121 hasConceptScore W2740620121C2908647359 @default.
• W2740620121 hasConceptScore W2740620121C2992929900 @default.
• W2740620121 hasConceptScore W2740620121C46111723 @default.
• W2740620121 hasConceptScore W2740620121C553184892 @default.
• W2740620121 hasConceptScore W2740620121C55493867 @default.
• W2740620121 hasConceptScore W2740620121C71924100 @default.
• W2740620121 hasConceptScore W2740620121C86803240 @default.
• W2740620121 hasConceptScore W2740620121C95444343 @default.
• W2740620121 hasConceptScore W2740620121C99454951 @default.
• W2740620121 hasLocation W27406201211 @default.
• W2740620121 hasOpenAccess W2740620121 @default.
• W2740620121 hasPrimaryLocation W27406201211 @default.
• W2740620121 hasRelatedWork W1974406897 @default.
• W2740620121 hasRelatedWork W2009900890 @default.
• W2740620121 hasRelatedWork W2021707569 @default.
• W2740620121 hasRelatedWork W2042051994 @default.
• W2740620121 hasRelatedWork W2464767991 @default.
• W2740620121 hasRelatedWork W2606758376 @default.
• W2740620121 hasRelatedWork W2740604595 @default.
• W2740620121 hasRelatedWork W2774806980 @default.
• W2740620121 hasRelatedWork W2902825390 @default.
• W2740620121 hasRelatedWork W2909923156 @default.
• W2740620121 hasRelatedWork W2967976783 @default.
• W2740620121 hasRelatedWork W3004351208 @default.
• W2740620121 hasRelatedWork W3027675147 @default.
• W2740620121 hasRelatedWork W3097127071 @default.
• W2740620121 hasRelatedWork W3098839489 @default.
• W2740620121 hasRelatedWork W3113179971 @default.
• W2740620121 hasRelatedWork W3176014217 @default.
• W2740620121 hasRelatedWork W3191568843 @default.
• W2740620121 hasRelatedWork W3211608602 @default.
• W2740620121 hasRelatedWork W43361395 @default.
• W2740620121 isParatext "false" @default.
• W2740620121 isRetracted "false" @default.
• W2740620121 magId "2740620121" @default.
• W2740620121 workType "article" @default.